Manuscripts should be sent to:
The Editor
Professor Alain Li Wan Po
Centre for Evidence Based Pharmacotherapy
Aston University
Aston Triangle
Birmingham
B4 7ET
UK
Tel: +44 (0)121 359 3611 ext 5530 or 5533
Fax: +44 (0)121 359 4693
e-mail: a.liwanpo@aston.ac.uk
Contributors must send three complete copies of the text, tables and figures, retaining one copy of each as the Editor does not accept responsibility for damage or loss of papers submitted. Authors are encouraged to submit their manuscripts electronically. Papers accepted may be subject to editorial revision without notice.
Papers are accepted on the understanding that they have not been and will not be published elsewhere. On acceptance, papers become the copyright of the Journal and all accepted papers should be accompanied by a copyright assignment form. To access this form please click here.
All papers must be written in concise English; spelling should follow The Concise Oxford Dictionary of Current English (Clarendon Press, Oxford) and abbreviations should conform with the lists of Units, Symbols and Abbreviations published by the Royal Society of Medicine (1972).
Manuscripts should be typewritten (double-spaced) on one side of the paper only. The title and short title (to be printed at the head of alternate pages), authors' names, qualifications and the department(s) where the work was carried out, and the name and full postal address of the author to whom all correspondence should be sent, should be typed on a separate sheet. Please include a telephone and a fax number and e-mail address when available. The text must be preceded by a short summary of the paper and up to six keywords.
Illustrations should not be included in the text but should accompany the manuscripts on separate sheets. Photographs should be well contrasted prints on glossy paper, each labelled on the back with the author's name and figure number and the 'top edge' identified. A separate sheet should contain all the captions for the figures. In the full-text online edition of the journal, figure legends may be truncated in abbreviated links to the full screen version. Therefore the first 100 characters of any legend should inform the reader of key aspects of the figure. Tables should be typed on separate sheets and numbered (with arabic numerals) in order of use in the text.
References should be indicated in the text by a figure in parentheses, i.e. (1), in order of citation. Lists of references should be typed on a separate sheet(s) and should be in numerical order in the following format:
1. Finkelstein E, Quintillani R, Lee R, Bracci A, Nightingale CH. (I978) Pharmacokinetics of oral cephalosporins: cephradine and cephalexin. Journal of Pharmaceutical Sciences,67, 1447-1450.
2. Aikawa R, Nakamo M, Arita TC. (1976) Fluorimetric determination of cephalexin in urine. Chemical and Pharmaceutical Bulletin, 24, 235-2355.
Accepted articles must be accompanied by a disk and file description form (http://www.blackwellpublishing.com/pdf/fdf.pdf), giving details of the software used, the type of computer, and any special (non-keyboard) characters used. Do not use the carriage return (enter) at the end of lines within a paragraph. Do not justify. Turn the hyphenation option off. Always enclose a hard-copy of figures and tables.
We would like to receive your artwork in electronic form. Please save vector graphics (e.g. line artwork) in Encapsulated Postscript format (EPS), and bitmap files (e.g half-tones) in Tagged Image File Format (TIFF). Ideally, vector graphics that have been saved in metafile (.WMF) or pict (.PCT) format should be embedded within the body of the text file. Detailed information on our digital illustration standards is available on the BSL Homepage at:
www.blackwell-science.com/elecmed/authors.htm
Correspondence is invited. Letters will only be considered if they contain constructive comments on published articles and if they are received in time to allow the authors a right of reply. Publication of correspondence is at the discretion of the Editor.
Proofs will be sent via e-mail as an Acrobat PDF (portable document format) file. The e-mail server must be able to accept attachments up to 4 MB in size. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following Web site:
http://www.adobe.com/products/acrobat/readermain.html
This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Proofs will be posted if no e-mail address is available; in your absence, please arrange for a colleague to access your e-mail to retrieve the proofs.
Two free copies of the issue are sent instead of offprints.
Evidence-based Pharmacotherapy Case Reports
For a detailed description of what constitutes an evidence-based pharmacotherapy case report, please refer to the Journal of Clinical Pharmacy and Therapeutics, 24, page 77. Each submission should use the following subheadings: Introduction, Clinical question, Search, Critical analysis and Summation. The text should be no more than 1200 words (not including references).
